Literature DB >> 230516

Production of choriogonadotropin-like factor by a microorganism.

T Maruo, H Cohen, S J Segal, S S Koide.   

Abstract

Extracts from an acetone powder preparation of a culture of a microorganism tentatively named Progenitor cryptocides contain choriogonadotropin (CG)-like factor as determined by radioimmunoassay with antiserum to human (h)CG beta subunit COOH-terminal peptide and radioreceptor assay with bovine corpus luteum membranes. Possible interference by proteases in the extracts was excluded. Immunoreactive materials reacting with antisera to hCG beta subunit and hCG beta subunit COOH-terminal peptide were also found in the extracts. No free alpha subunit was detected. The CG-like factor was purified by chromatography on Sephadex G-100, concanavalin A-Sepharose, and DEAE-Sephadex A-50. The factor was adsorbed by concanavalin A-Sepharose, suggesting that it contains mannose and glucose moieties. The factor was eluted at the same position as standard hCG on Sephadex G-100. It dissociated into two bands when subjected to sodium dodecyl sulfate/polyacrylamide gel electrophoresis; the bands corresponded to the respective standard hCG subunits. The biological activity of the purified factor as determined by the rat uterine weight assay and the ovarian weight assay was equivalent to 380 (95% confidence limits: 320-490) and 880 (780-1020) international units/mg, respectively. It can be concluded from the present results that a microorganism produces a glycoprotein that is biologically active and has physicochemical properties similar to those of hCG.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 230516      PMCID: PMC411919          DOI: 10.1073/pnas.76.12.6622

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  24 in total

1.  Sources of error in clinical bioassays of serum chorionic gonadotropin.

Authors:  E DICZFALUSY; J A LORAINE
Journal:  J Clin Endocrinol Metab       Date:  1955-04       Impact factor: 5.958

2.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

3.  Properties of the subunits of human chorionic gonadotropin.

Authors:  F J Morgan; R E Canfield; J L Vaitukaitis; G T Ross
Journal:  Endocrinology       Date:  1974-06       Impact factor: 4.736

4.  Interaction of human chorionic gonadotropin with rat gonads.

Authors:  Y Ashitaka; S S Koide
Journal:  Fertil Steril       Date:  1974-02       Impact factor: 7.329

5.  Production of human chorionic gonadotropin in vitro by a cell line derived from a carcinoma of the lung.

Authors:  A S Rabson; S W Rosen; A H Tashijan; B D Weintraub
Journal:  J Natl Cancer Inst       Date:  1973-03       Impact factor: 13.506

6.  Biological properties of hCG after removal of terminal sialic acid and galactose residues.

Authors:  T Tsuruhara; M L Dufau; J Hickman; K J Catt
Journal:  Endocrinology       Date:  1972-07       Impact factor: 4.736

7.  A method for producing specific antisera with small doses of immunogen.

Authors:  J Vaitukaitis; J B Robbins; E Nieschlag; G T Ross
Journal:  J Clin Endocrinol Metab       Date:  1971-12       Impact factor: 5.958

8.  The reliability of molecular weight determinations by dodecyl sulfate-polyacrylamide gel electrophoresis.

Authors:  K Weber; M Osborn
Journal:  J Biol Chem       Date:  1969-08-25       Impact factor: 5.157

Review 9.  Gonadotropins and their subunits: basic and clinical studies.

Authors:  J L Vaitukaitis; G T Ross; G D Braunstein; P L Rayford
Journal:  Recent Prog Horm Res       Date:  1976

10.  Studies on in vitro synthesis and secretion of human chorionic gonadtropin and its subunits.

Authors:  T Maruo
Journal:  Endocrinol Jpn       Date:  1976-04
View more
  16 in total

Review 1.  Development of hormone receptors: conclusion.

Authors:  K D Döhler
Journal:  Experientia       Date:  1986-07-15

Review 2.  Receptors for intercellular messenger molecules in microbes: similarities to vertebrate receptors and possible implications for diseases in man.

Authors:  D LeRoith; C Roberts; M A Lesniak; J Roth
Journal:  Experientia       Date:  1986-07-15

3.  Immunization procedures for E. coli proteins.

Authors:  V R Anicetti; M A Simonetti; L L Blackwood; A J Jones; A B Chen
Journal:  Appl Biochem Biotechnol       Date:  1989-11       Impact factor: 2.926

4.  Antibodies to bacterial vaccines demonstrating specificity for human choriogonadotropin (hCG) and immunochemical detection of hCG-like factor in subcellular bacterial fractions.

Authors:  G J Domingue; H F Acevedo; J E Powell; V C Stevens
Journal:  Infect Immun       Date:  1986-07       Impact factor: 3.441

5.  The influence of the normal microbial flora on the susceptibility of rats to experimental autoimmune thyroiditis.

Authors:  W J Penhale; P R Young
Journal:  Clin Exp Immunol       Date:  1988-05       Impact factor: 4.330

Review 6.  Controversies in plastic surgery: suction-assisted lipectomy (SAL) and the hCG (human chorionic gonadotropin) protocol for obesity treatment.

Authors:  T Vogt; D Belluscio
Journal:  Aesthetic Plast Surg       Date:  1987       Impact factor: 2.326

7.  Effects of antibodies to choriogonadotropin in malignant growth. II. Solid transplantable rat tumors.

Authors:  J A Kellen; A Kolin; A Mirakian; H F Acevedo
Journal:  Cancer Immunol Immunother       Date:  1982       Impact factor: 6.968

8.  Autoimmunity: a decision theory model.

Authors:  J A Morris
Journal:  J Clin Pathol       Date:  1987-02       Impact factor: 3.411

9.  Acquisition of alpha 1-Antitrypsin by a pathogenic strain of Trichomonas vaginalis.

Authors:  K M Peterson; J F Alderete
Journal:  Infect Immun       Date:  1983-05       Impact factor: 3.441

10.  Evolutionary origins of vertebrate hormones: substances similar to mammalian insulins are native to unicellular eukaryotes.

Authors:  D Le Roith; J Shiloach; J Roth; M A Lesniak
Journal:  Proc Natl Acad Sci U S A       Date:  1980-10       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.